Willcox M D
Institute of Dental Research, Surrey Hills, NSW, Australia.
J Med Microbiol. 1995 Dec;43(6):405-10. doi: 10.1099/00222615-43-6-405.
The "Streptococcus milleri" (SMG) group have been shown to possess factors in vitro that may be involved in pathogenesis. All SMG strains are able to bind fibronectin via a cell-surface protein; the binding ranged from 12 to 198 mol/cell. Strains also bound to platelet-fibrin or fibrin clots and fibrinogen, giving maximum adhesion values of 16.5%, 21.8% and 151 mol/cell respectively. Members of the species S. constellatus produced thrombin-like activity. Lancefield group C SMG aggregated rat platelets, a bacterial cell-surface protein acting as mediator in the reaction. Most of the in-vitro factors did not correlate with each other, an indication that SMG strains possess a wide variety of pathogenic properties that may be involved in the production of abscesses or endocarditis. However, there was a correlation between the binding of large amounts of fibrinogen ( > 100 mol/cell) and the ability to aggregate platelets. This suggests that fibrinogen binding may aid in platelet aggregation.
“米勒链球菌”(SMG)组已被证明在体外具有可能参与发病机制的因子。所有SMG菌株都能够通过一种细胞表面蛋白结合纤连蛋白;结合量在12至198摩尔/细胞之间。菌株还能与血小板 - 纤维蛋白或纤维蛋白凝块以及纤维蛋白原结合,最大黏附值分别为16.5%、21.8%和151摩尔/细胞。星座链球菌的菌株具有凝血酶样活性。兰斯菲尔德C组SMG使大鼠血小板聚集,一种细菌细胞表面蛋白在该反应中起介导作用。大多数体外因子彼此之间没有相关性,这表明SMG菌株具有多种可能参与脓肿或心内膜炎形成的致病特性。然而,大量纤维蛋白原结合(>100摩尔/细胞)与血小板聚集能力之间存在相关性。这表明纤维蛋白原结合可能有助于血小板聚集。